# High-dose, Short-term Steroid and Low-dose Long-term Steroid Use in ARDS Caused by COVID-19

> **NCT05047874** · — · UNKNOWN · sponsor: **Biruni University** · enrollment: 200 (estimated)

## Conditions studied

- Short-term (3 Days) High-dose (1000 mg) Systemic Methylprednisolone

## Interventions

- **BEHAVIORAL:** systemic methylprednisolone

## Key facts

- **NCT ID:** NCT05047874
- **Lead sponsor:** Biruni University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-09-20
- **Primary completion:** 2021-10-20
- **Final completion:** 2021-10-30
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2021-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05047874

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05047874, "High-dose, Short-term Steroid and Low-dose Long-term Steroid Use in ARDS Caused by COVID-19". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT05047874. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*